美丽田园医疗健康（02373）：美业龙头，气场全开

Investment Rating - The report assigns a "Buy" rating for the company, with a target price of HKD 31.21 based on a projected average PE of 15 times for 2026 [4][7]. Core Insights - The company has established itself as a leader in the beauty and healthcare industry in China, with over 700 stores and a diversified business model that includes beauty services, medical aesthetics, and health management [7][14]. - The domestic beauty industry is characterized by a fragmented market that is ripe for consolidation, with the company holding a market share of approximately 0.29% in the beauty services sector and 0.53% in medical aesthetics [7][38]. - The company's dual beauty and health model enhances operational efficiency and customer acquisition, supported by a strong digital infrastructure that improves service delivery and customer retention [7][30]. Financial Summary - Revenue is projected to grow from CNY 21.45 billion in 2023 to CNY 25.72 billion in 2024, with a CAGR of 12.79% from 2019 to 2024 [3][28]. - Adjusted net profit is expected to increase from CNY 2.52 billion in 2024 to CNY 3.8 billion in 2025, reflecting a growth rate of over 40% [3][28]. - The company’s gross margin is expected to stabilize and improve, with significant contributions from the health management services segment [30][34]. Business Model and Market Position - The company operates under a "dual beauty and dual health" model, which integrates beauty services with health management, creating a comprehensive service ecosystem [7][44]. - The beauty services segment accounts for over 50% of revenue, while medical aesthetics and health management services are steadily increasing their contribution [7][22]. - The company has a strong management team with extensive experience in the beauty industry, which supports its strategic initiatives and operational execution [17][20]. Industry Outlook - The beauty services market in China is projected to grow to CNY 640.2 billion by 2030, with a CAGR of 5.3% from 2024 to 2030, indicating a robust growth trajectory [38][39]. - The medical aesthetics market is expected to reach CNY 415.7 billion by 2030, with a CAGR of 15.5%, driven by increasing consumer acceptance of non-surgical procedures [53][54]. - The health management services sector is also anticipated to grow significantly, with a projected market size of CNY 29 billion by 2030, reflecting a CAGR of 16.2% [7][38].